You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. IGF OT IGF A STAGE BASED MOBILE INTERVENTION FOR SUBSTANCE USE DISORDERS IN PRIMARY CARE N DA POP SEPTEMBER FEBRUARY BASE AWARD

    SBC: Pro-Change Behavior Systems, Inc.            Topic: NIDA

    Not Available

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  2. IGF OT IGF RADIOPROTECTOR FOR HEAD AND NECK CANCER PERIOD OF PERFORMANCE

    SBC: BIOMIMETIX JV LLC            Topic: ODNCI

    This SBIR Program is to complete the development of a novel metalloporphyrin antioxidant compound BMX to be used as a radioprotector in the treatment of patients with head and neck cancer undergoing radiation therapy This drug product has been produced to GMP quality safety toxicology completed in one species and a high degree of efficacy demonstrated for both protecting against radiation ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  3. IGF OT IGF TREATMENT OF TUBERCULOSIS WITH INHALED DELIVERY OF CLOFAZIMINE

    SBC: AEROPHASE, INC.            Topic: NIAID

    Not Available

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  4. IGF OT IGF SMOKESCREEN GENETIC SCREENING TOOL FOR TOBACCO DEPENDENCE and TREATMENT APPROACHES POP MOD SUPPLEMENT WITHIN SCOPE AND EXTENSION

    SBC: BIOREALM, LLC            Topic: NIDA

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  5. IGF OT IGF VALIDATION OF MOBILE TECHNOLOGIES FOR CLINICAL ASSESSMENT

    SBC: Pro-Change Behavior Systems, Inc.            Topic: NCI

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  6. IGF OT IGF CONTRACT TITLE RADIATION MODULATORS FOR HEAD AND NECK CANCERPOP

    SBC: SUVICA INC            Topic: NCI

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  7. IGF OT IGF FY IWIN NAVIGATING YOUR PATH TO WELL BEING SBIR PHASE II BASE AWARD PERIOD OF PERFORMANCE

    SBC: Pro-Change Behavior Systems, Inc.            Topic: NIDA

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  8. SERS and Flourescent Dual Mode Dengue Diagnostic Strip Incorporate Novel Nanoparticals

    SBC: VITAN-BIOTECH LLC            Topic: ODCDC

    Rapid sensitive and specific diagnosis of the Dengue virus DENV infection is important for both patient care and epidemiologic studies Current Dengue diagnostic tests are either time consuming expensive or lack of sensitivity We propose to develop a novel low cost lateralflow immunoassay LFIA strip capable of sensitive detection of DENV NS antigen The proposed test strip synergically in ...

    SBIR Phase I 2015 Department of Health and Human ServicesCenters for Disease Control and Prevention
  9. Smartphone Technology for Parents and Teens: Improving Vaccination Uptake

    SBC: KLEIN BUENDEL, INC.            Topic: NICHD

    DESCRIPTION provided by applicant Vaccinations for adolescents in the U S tetanus diphtheria and acellular pertussis Tdap meningococcal conjugate vaccine MCV Human Papillomavirus HPV vaccines Gardasil and Cervarex remain well below the Centers for Disease Control and Prevention CDC goals and especially so for the HPV vaccines These vaccine deficits are pronounced among minor ...

    STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  10. Scientific Merit and Feasibility of Fructokinase Inhibiton for Obesity

    SBC: COLORADO RESEARCH PARTNERS LLC            Topic: NIDDK

    DESCRIPTION provided by applicant Intake of added sweeteners high fructose corn syrup and sucrose independently predicts the development of obesity metabolic syndrome and diabetes Despite recommendations by WHO and the AHA to reduce sugar intake to to percent of total energy intake the mean intake of added sugars remains percent of the diet and percent of the population ingest ...

    STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government